BioSig Technologies, Inc. BSGM

Set alert

Price alert · BSGM

All alert types
6.10 0.00 0.00%

At close · Sep 11

4.36 Day range 6.12
4.36 52-week range 6.12
Open
4.44
Prev close
6.10
Mkt cap
191.13M
Vol
3.01M
Avg vol
918.25K
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
4.36
High
6.12
Forward P/E
-1.95
Beta
0.35
Short ratio
0.56
Inst. own
0.00%
Dividend
0.00
Ex-div date
50-d avg
1.38
200-d avg
0.937115
1y target
2.75

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for BSGM has not been loaded yet. Try again in a moment.

Key statistics

Market cap
25.51M
Enterprise value
27.93M
Trailing P/E
0.00
Forward P/E
-1.95
PEG ratio
0.00
Price / sales
637.69
Price / book
0.00
EPS (TTM)
-1.34
Beta
0.35
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
40.00K
Revenue growth
0.00%
Free cash flow
-4.40M
Total cash
2.10M
Total debt
282.00K
Return on equity
-6342.03%
Shares outstanding
17.23M
Short % of float
1.27%
50-day average
1.38
200-day average
0.937115

Financials — quick view

All financials
BSGM Revenue — quarterly 0
2021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 2025
BSGM Net income — quarterly -20.37M
2021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 2025
BSGM EPS — quarterly -0.74
2021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 2025

Upgrades / downgrades

BSGM analyst upgrades and downgrades
DateFirmActionFromTo
Dec 5, 2024Ascendiant CapitalmainBuyBuy

About BioSig Technologies, Inc.

BioSig Technologies, Inc., a medical technology company, focuses on deciphering the body's electrical signals starting with heart rhythms. It delivers unprecedented cardiac signal clarity, ending the reliance on mixed signals and reading between the lines. The company's product, the PURE EP Platform, provides real-time signal visualization allowing physicians to perform targeted cardiac ablation procedures with increased procedural efficiency and efficacy. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
biosig.com

News

Your note

Sign in to keep a note on BSGM — it syncs with the Stock Master app.

Insider holders

BSGM insider holders
InsiderRelationLatest transactionDateShares held
ABELMAN STEVEN E. J.D.DirectorStock Award(Grant)Jul 25, 202480,000
AMATO ANTHONY N.Chief Executive OfficerStock Award(Grant)Sep 10, 20242,108,200
BAER CHRISDirectorStock Award(Grant)Jul 25, 202480,000
BARRY JAMES JDirectorStock Award(Grant)Aug 14, 202371,249
BROWNE DONALD F.DirectorStock Award(Grant)Jul 25, 202480,000
FLEMING GRAYOfficerStock Award(Grant)Nov 29, 2023463,556

Institution ownership

BSGM institution ownership
Holder% heldSharesValueReported
Steward Partners Investment Advisory, LLC0.01%9001.33KJun 29, 2024

Fund ownership

BSGM fund ownership
Holder% heldSharesValueReported
Northern Small Cap Core Fund0.00%11Sep 29, 2024